Core Scientific, Inc. (CORZ) is the issuer in a Schedule 13G reporting shared voting and dispositive power over 24,488,600 shares, listed as 7.6% of the class. The reporting persons are MFN Partners, LP; MFN Partners GP, LLC; MFN Partners Management, LP; MFN Partners Management, LLC; Michael F. DeMichele; and Farhad Nanji. The reported amount comprises 16,700,000 shares of common stock and 7,788,600 shares issuable upon exercise of options. The filing identifies MFN Partners, LP as the direct holder; each reporting person disclaims beneficial ownership except to the extent of its or his pecuniary interest. The percentage calculation uses 321,340,441 common shares outstanding as of July 23, 2026. DeMichele and Nanji are managing members of MFN GP and MFN LLC.
Core Scientific, Inc. (CORZ) Chief Legal and Administrative Officer Todd M. Duchene reported two direct sales of common stock on October 26, 2026: 4,500 shares at a weighted average price of $13.2653, with sale prices ranging from $12.71 to $13.70, and 5,500 shares at a weighted average price of $13.8000, with sale prices ranging from $13.71 to $13.91. Both sales were made under a Rule 10b5-1 trading plan adopted December 5, 2025. Duchene also reported 700,000 shares held indirectly by a grantor retained annuity trust of which he is sole trustee.
Core Scientific, Inc. (CORZ) Chief Executive Officer Adam Taylor Sullivan reported that 21,839 shares were withheld on October 16, 2026, to satisfy withholding tax obligations upon vesting of previously granted restricted stock units. The transaction was not an open-market sale. His reported direct holdings following the transaction were 4,391,079 shares; the reported price was $14.4550 per share.
Core Scientific, Inc. Chief Legal and Administrative Officer Todd M. Duchene sold 10,000 shares on October 19, 2026, at a weighted average price of $13.8744 per share under a Rule 10b5-1 trading plan adopted December 5, 2025; transaction prices ranged from $13.62 to $14.14, inclusive.
On October 16, 2026, 6,382 shares were withheld to satisfy tax obligations upon vesting of previously granted restricted stock units, not as an open-market sale. Duchene also reported 700,000 shares held indirectly by a grantor retained annuity trust of which he is sole trustee.
Core Scientific, Inc. (CORZ) Chief Legal and Administrative Officer Todd M. Duchene sold 10,000 common shares on October 12, 2026, at a weighted average price of $15.1160 per share; the shares were sold in multiple transactions ranging from $14.98 to $15.40. The sale was made under a Rule 10b5-1 trading plan adopted December 5, 2025. After the sale, he held 1,159,668 shares directly. A grantor retained annuity trust of which he is sole trustee held 700,000 shares.
Core Scientific, Inc. common stock is the subject of a proposed sale of 140,000 shares for the account of the Todd DuChene Revocable Trust, with an aggregate market value of $2,157,400.00. Morgan Stanley Smith Barney LLC is named as broker and NASDAQ as the sale venue. Todd DuChene is identified as an officer. The notice also lists prior sales by the trust under 10b5-1, including 10,000 shares on October 5, 2026.
Todd M. Duchene, Core Scientific, Inc.’s Chief Legal and Administrative Officer, sold 10,000 common shares on October 5, 2026, at a weighted average of $16.3056 per share under a Rule 10b5-1 trading plan adopted December 5, 2025. The shares were sold in multiple transactions at prices ranging from $15.90 to $16.75. Following the sale, Duchene held 1,169,668 shares directly; a grantor retained annuity trust of which he is sole trustee held 700,000 shares.
On October 1, 2026, Core Scientific, Inc. CEO Adam Taylor Sullivan had 23,508 shares withheld to satisfy tax obligations when previously granted restricted stock units vested; this was not an open-market sale. The reported price was $15.98 per share, and his direct holdings afterward were 4,412,918 shares.
Core Scientific, Inc. Chief Legal and Administrative Officer Todd M. Duchene had 8,228 shares withheld on October 1, 2026, to satisfy tax obligations upon vesting of previously granted restricted stock units; the reported price was $15.98 per share. The withholding was not an open-market sale. After the transaction, he directly held 1,179,668 shares; a grantor retained annuity trust of which he is sole trustee held 700,000 shares indirectly.
Core Scientific, Inc. Chief Legal and Administrative Officer Todd M. Duchene reported selling 10,000 shares of common stock on September 28, 2026, at a weighted average price of $16.7586 per share. The shares were sold in multiple transactions at prices ranging from $16.44 to $17.20 under a Rule 10b5-1 trading plan adopted December 5, 2025. After the sale, Duchene directly held 1,187,896 shares; 700,000 shares were held by a grantor retained annuity trust for which he is sole trustee.